Review
Published on 30 May 2023
Hydroxychloroquine-induced Retinal Toxicity
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1196783
- 16,402 views
- 26 citations
Type at least 3 characters
2,439 articles
Review
Published on 30 May 2023
Research trends and hotspots of post-stroke cognitive impairment: a bibliometric analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1184830
- 8,340 views
- 14 citations
Original Research
Published on 30 May 2023
Intranasal cerium oxide nanoparticles improves locomotor activity and reduces oxidative stress and neuroinflammation in haloperidol-induced parkinsonism in rats
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1188470
- 4,939 views
- 14 citations
Original Research
Published on 26 May 2023
Essential role of microglia in the fast antidepressant action of ketamine and hypidone hydrochloride (YL-0919)
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1122541
- 5,208 views
Original Research
Published on 25 May 2023
Opioid use in the era of COVID-19: a multifaceted study of the opioid epidemic in Canada
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1122441
- 6,097 views
- 2 citations
Original Research
Published on 25 May 2023
Cannabigerol modulates α2-adrenoceptor and 5-HT1A receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1183019
- 7,191 views
- 8 citations
Editorial
Published on 24 May 2023
Editorial: Investigating the role of biological pathways involved in brain disorder and infection
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1217333
- 2,345 views
Original Research
Published on 22 May 2023
Puerarin inhibited oxidative stress and alleviated cerebral ischemia-reperfusion injury through PI3K/Akt/Nrf2 signaling pathway
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1134380
- 8,145 views
- 50 citations
Original Research
Published on 19 May 2023
Profile and potential role of novel metabolite biomarkers, especially indoleacrylic acid, in pathogenesis of neuromyelitis optica spectrum disorders
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1166085
- 5,715 views
- 6 citations
Brief Research Report
Published on 17 May 2023
The olfactory Olfr-78/51E2 receptor interacts with the adenosine A2A receptor. Effect of menthol and 1,8-cineole on A2A receptor-mediated signaling
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1108617
- 4,147 views
- 4 citations
Original Research
Published on 17 May 2023
Medial septum glutamatergic neurons modulate nociception in chronic neuropathic pain via projections to lateral hypothalamus
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1171665
- 5,334 views
- 2 citations
Systematic Review
Published on 16 May 2023
Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1175372
- 9,161 views
- 5 citations
Original Research
Published on 15 May 2023
Integrated transcriptome and metabolome analysis to investigate the mechanism of intranasal insulin treatment in a rat model of vascular dementia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1182803
- 5,142 views
- 21 citations
Mini Review
Published on 12 May 2023
Fenfluramine: a plethora of mechanisms?
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1192022
- 11,625 views
- 27 citations
Original Research
Published on 10 May 2023
Translating clinical notes into quantitative measures—a real-world observation on the response to cholinesterase inhibitors or selective serotonin reuptake inhibitors prescribed to outpatients with dementia using electronic medical records
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1177026
- 3,283 views
Original Research
Published on 10 May 2023
Antidepressant-like activity of a brain penetrant HCN channel inhibitor in mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1159527
- 4,873 views
- 9 citations